tradingkey.logo

Palvella Therapeutics Inc <PVLA.OQ> expected to post a loss of $1.21 a share - Earnings Preview

ReutersMay 13, 2025 2:45 PM
  • Palvella Therapeutics Inc PVLA.OQ PVLA.O is expected to report resultson May 15 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Palvella Therapeutics Inc is for a loss of $1.21 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 65.4% in the last three months. ​

  • Wall Street's median 12-month price target for Palvella Therapeutics Inc is $49.00​, above​ its last closing price of $20.75. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.66

-0.64

-2.72

Missed

-321.7

2024

​​

-3.70

Sep. 30 2023

-8.80

-8.80

3.20

Beat

136.4​

Jun. 30 2023

-12.80

-12.80

4.00

Beat

131.3

Mar. 31 2023

-10.73

-11.20

-14.40

Missed

-28.6

This summary was machine generated May 13 at 14:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI